In 2011, the Bohn lab noted antinociception towards equally chemically induced and inflammation-derived ache, and experiments indicated deficiency of opioid receptor modulation, but were not able to define a certain target. "We confirmed that conolidine binds on the recently recognized opioid receptor ACKR3, though displaying no affinity for another https://juliusw357jcu1.wikigdia.com/user